£520.00

It has never been this cheap. We have no record of a lower price.

£520 today · cheaper than every other day in the last 3 months

US Macular Degeneration Treatment Outlook 2023-2028 Study

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 24 days · 24 data points (no recent data)

Historical
Generating forecast…
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 03 August 2026 08 August 2026 14 August 2026 20 August 2026 26 August 2026
View at Amazon ↗

Price data last checked 67 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 24 days • 1 price levels

Days at Price
24 days 0 6 12 18 24 £520 Days at Price

Price Analysis

Most common price: £520 (24 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 24 days

Description

Gain detailed market intelligence with this comprehensive study on the 2023-2028 outlook for macular degeneration treatments in the United States. This report provides critical data on latent demand, expressed as potential industry earnings (P.I.E.) in millions of U.S. dollars. By analyzing approximately 12,600 cities across the country, the study offers a granular view of market opportunities. It includes comparative benchmarks by reporting the percent share each city holds relative to its state and the United States as a whole. This statistical approach provides the necessary data to build effective distribution and sales force strategies based on econometric insights.

Key Features

Provides latent demand estimates in millions of U.S. dollars for macular degeneration treatments across the United States.

Includes potential industry earnings (P.I.E.) data for approximately 12,600 cities to assist in market analysis.

Offers comparative benchmarks by showing the percent share of each city relative to its state and the entire country.

Supports the development of distribution and sales force strategies through detailed statistical data.

Covers a specific market outlook period spanning from 2023 to 2028.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
10 November 2022

Similar Products You Might Like

Macular Degeneration Treatment Outlook in India 2023-2028
99% match

Macular Degeneration Treatment Outlook in India 2023-2028

£515.00 26 Aug 2026
The 2023-2028 Outlook for Macular Degeneration Treatments in Japan
99% match

The 2023-2028 Outlook for Macular Degeneration Treatments in Japan

£495.00 28 Oct 2026
Macular Degeneration Treatment Outlook 2023-2028 Study
98% match

Macular Degeneration Treatment Outlook 2023-2028 Study

£490.00 22 Aug 2026
US Proliferative Diabetic Retinopathy Treatment Outlook 2023-2028
98% match

US Proliferative Diabetic Retinopathy Treatment Outlook 2023-2028

£520.00 26 Aug 2026
The 2023-2028 Outlook for Myopia and Presbyopia Treatments in the United States
98% match

The 2023-2028 Outlook for Myopia and Presbyopia Treatments in the United States

£520.00 28 Oct 2026
The 2023-2028 Outlook for Vision Care in the United States
98% match

The 2023-2028 Outlook for Vision Care in the United States

£520.00 15 Aug 2026
Myopia and Presbyopia Treatments in India Outlook 2023-2028
98% match

Myopia and Presbyopia Treatments in India Outlook 2023-2028

£515.00 23 Aug 2026
Vision Care in India 2023-2028 Outlook - Market Study
98% match

Vision Care in India 2023-2028 Outlook - Market Study

£515.00 21 Aug 2026
The 2023-2028 Outlook for Uveitis Drugs in India
98% match

The 2023-2028 Outlook for Uveitis Drugs in India

£515.00 28 Aug 2026
The 2023-2028 Outlook for Anti-Vascular Endothelial Growth Factor Therapy (Anti-VEGF) for Non-Infectious Macular Edema in the United States
97% match

The 2023-2028 Outlook for Anti-Vascular Endothelial Growth Factor Therapy (Anti-VEGF) for Non-Infectious Macular Edema in the United States

£520.00 03 Oct 2026
Optic Nerve Disorders Treatment Outlook 2023-2028 Study
97% match

Optic Nerve Disorders Treatment Outlook 2023-2028 Study

£520.00 20 Aug 2026
Age-Related Macular Degeneration: Etiology, Diagnosis and Management - A Glance at the Future
97% match

Age-Related Macular Degeneration: Etiology, Diagnosis and Management - A Glance at the Future

IntechOpen

£119.00 18 Sep 2026
US Glass Lens Vision Care Outlook 2023-2028 Market Study
97% match

US Glass Lens Vision Care Outlook 2023-2028 Market Study

£520.00 28 Oct 2026
The 2026-2031 World Outlook for Diabetic Macular Edema
97% match

The 2026-2031 World Outlook for Diabetic Macular Edema

£885.00 02 Sep 2026
Age Related Macular Degeneration – The Recent Advances in Basic Research and Clinical Care
97% match

Age Related Macular Degeneration – The Recent Advances in Basic Research and Clinical Care

IntechOpen

£139.00 29 Sep 2026
Optic Nerve Disorders Treatments India Outlook 2023-2028
97% match

Optic Nerve Disorders Treatments India Outlook 2023-2028

£515.00 22 Aug 2026
The 2023-2028 Outlook for Optical Goods and Eye Care Products in the United States
97% match

The 2023-2028 Outlook for Optical Goods and Eye Care Products in the United States

£520.00 23 Aug 2026
The 2026-2031 World Outlook for Myopia and Presbyopia Treatments
97% match

The 2026-2031 World Outlook for Myopia and Presbyopia Treatments

£885.00 28 Oct 2026
India Eye Drops Market Outlook 2023-2028 Study Report
97% match

India Eye Drops Market Outlook 2023-2028 Study Report

£515.00 26 Aug 2026
The 2027-2032 World Outlook for Myopia and Presbyopia Treatments
97% match

The 2027-2032 World Outlook for Myopia and Presbyopia Treatments

£890.00 09 Oct 2026
The 2023-2028 Outlook for Diabetic Retinopathy Treatments in China
97% match

The 2023-2028 Outlook for Diabetic Retinopathy Treatments in China

£495.00 15 Aug 2026
US Dry Eye Syndrome Treatment Outlook 2023-2028 Report
97% match

US Dry Eye Syndrome Treatment Outlook 2023-2028 Report

£520.00 22 Aug 2026
The 2021-2026 World Outlook for Ophthalmic Diagnostic Equipment
97% match

The 2021-2026 World Outlook for Ophthalmic Diagnostic Equipment

£795.00 29 Oct 2026
The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in China
97% match

The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in China

£495.00 29 Oct 2026